Pharma packaging group West announces 330 jobs for Dublin
Announcement is first major investment by a US multinational following Trump victory in presidential election
Novo Nordisk
Weight-loss drugs show promise in tackling opioid and alcohol abuse
Academic notes while Ozempic might prevent overdoses, weight loss drug may not actually reduce or end substance use
Europe’s Stoxx 600 index posts biggest one-day gain since November
Strong day for banking stocks lifts Irish market, while Airbnb and Puma fall after weak outlook statements
Obesity drugmaker Novo Nordisk misses profit forecast
Danish company employs about 450 people in Ireland
Novo Nordisk drops Dublin factory plan
Seen & Heard: Inheritance tax reduction, Press Up stake and Spar sale
US shares advance as markets eye Apple results
Iseq index outperforms its peers, adding 1.5% after positive updates from Smurfit Kappa and Glenveagh Homes
EU rules drive pharma backers to the US, says IDA Ireland chief
Europe’s regulations have become ‘too burdensome’ and could hinder innovation, argues Michael Lohan
Europe’s magnificent 11 stocks – the Granolas
Continent’s top firms drove most of European equity gains last year
European shares jump 1% after ECB rate decision
Pan-European Stoxx 600 extends gains and hit a fresh record high, rising 1 per cent
Forget Tesla: Eli Lilly can join magnificent seven club
Drug maker trades on multiples unheard of in pharma sector over anticipated sales of weight loss drug
Is Novo Nordisk set to become Europe’s first trillionaire company?
Stocktake: Europe’s most valuable company last week exceeded a market value of $500bn after reporting better-than-expected earnings
Novo Nordisk passes $500 billion value on Wegovy frenzy
The drug maker has struggled to keep up with demand for both Wegovy and Ozempic
Planet Business: A $1 billion mega-tour and other numbers of the year
From flight cancellation misery and forfeited pay to corporation tax hauls and obesity drug bonanzas, everything in 2023 had either a value or a cost
Ozempic and Wegovy maker Novo Nordisk set to build large manufacturing facility in Dublin
News of new factory comes after Danish group announced in December the purchase of drug manufacturing plant in Athlone in order to keep up with demand for weight-loss drugs
Pfizer outlook gloomy after annus horribilis in 2023
Pharmaceutical giant suffers a post-Covid-19 hangover as demand for pandemic vaccines and medicines falls sharply
Ozempic maker Novo Nordisk buys Irish drug manufacturing plant in €85m deal
Danish weight loss and diabetes specialist is looking to develop a tablet form of its blockbuster obesity treatments
Ozempic drug-maker pushed Government to oppose EU pharma reforms
Proposals would lower time period a company has protection over research behind drugs they develop
Regulator warned GPs over Ozempic advertising breaches
Correspondence between health officials details 'high level of concern' about obesity drug shortages
BP chair rules himself out as next chief executive after Bernard Looney exit
Helge Lund has sought to reassure investors following Looney’s abrupt departure
Obesity drugs make Novo Nordisk Europe’s biggest company
Company boosted by trial results showing weight loss drug also cuts risk of heart attack by 20%
Cable television ‘on the edge of a precipice’ in US as tennis stars are forced to improvise
Planet Business: Pre-Swift concert film hits, Qantas’s under-fire chairman, and the ascent of Novo Nordisk
Pharma giant behind Ozempic paid doctors thousands in speaking fees and expenses
Novo Nordisk profits surging due to huge demand for obesity drugs Ozempic and Wegovy
Significant surge in Irish seizures of weight-loss drugs sold illegally online
Website advertising Ozempic for sale online falsely using address of north Dublin pharmacy
US targets 10 drugs for pricing negotiations in crackdown on costs
Expensive medicines made by Pfizer, J&J and Merck selected for talks in biggest pharma shake-up in decades
European shares climb as traders bet on end to interest rate increases
Sportswear companies among fallers after downbeat profit forecast from US retailer Foot Locker
Novo Nordisk says obesity pill leads to 15% weight loss
Danish drugmaker pushing for US and EU approval but has struggled to meet demand for its Ozempic and Wegovy drugs
LVMH becomes first European company to reach $500bn market value
French luxury group’s share price rises as sector continues to benefit from China rebound
Slimming drug Wegovy triggers significant forecast upgrade at Novo Nordisk
Demand for diabetes drug Ozempic, also used off label for weight loss, also fuels near doubling of sales and profit expectations
Strong corporate earnings see European markets end April on high note
US shares fall on inflation worries
European shares boosted by strong earnings and reports of M&A
Iseq closes slightly higher with house builders Cairn and Glenveagh in focus
European stocks drop as Omicron worries intensify
Travel stocks fell 1 per cent, but were above their intra-day lows touched earlier in session
Trials of new drug to tackle obesity ‘exceed expectations’ – Irish consultant
Obesity drug resulted in weight loss of more than 10%, research shows
Ryanair climbs on news of further shake up of UK travel restrictions
Fears about falling Chinese demand send iron ore prices plunging in London
Dublin-based Prothena to sell drug to Novo Nordisk in $1.2bn deal
Drugmaker, which spun out of Elan is selling PRX004 so it can focus on other therapies
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices